ConductScience.org, home

Paper36735698

Antisense oligonucleotides to therapeutically target SARS-CoV-2 infection.

Qiao Y and 15 others. PLoS One, 2023. Cited by 16 papers, by iCite.

Cite this record

ConductScience Library. Antisense oligonucleotides to therapeutically target SARS-CoV-2 infection. Papers, record 36735698. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36735698

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Antisense oligonucleotides to therapeutically target SARS-CoV-2 infection.
PubMed
Journal
PLoS One
PubMed
Year
2023
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
16
iCite
Relative citation ratio, by iCite
1.43
iCite
Revised in PubMed
2024-04-13
PubMed

Authors16

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Qiao YYuanyuan
2Wotring JWJesse Whttps://orcid.org/0000-0002-7085-7582
3Zhang CJCharles J
4Jiang XXia
5Xiao LLanbo
6Watt AAndy
7Gattis DDanielle
8Scandalis EEli
9Freier SSusan
10Zheng YYang
11Pretto CDCarla D
12Ellison SJStephanie J
13Swayze EEEric E
14Guo SShuling
15Sexton JZJonathan Z
16Chinnaiyan AMArul Mhttps://orcid.org/0000-0001-9282-3415

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
SARS-CoV-2Major topic
COVID-19Major topic
Humans
Angiotensin-Converting Enzyme 2
Oligonucleotides, Antisense
Pandemics
Peptidyl-Dipeptidase A
Virus Internalization

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 DK120623NIDDK NIH HHSUnited StatesR01DK120623PubMed and NIHNIH RePORTER
Howard Hughes Medical InstituteUnited StatesPubMedPubMed

Download CSV of grants

References41

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
134614327Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar.N Engl J Med2021https://conductscience.org/library/papers/34614327PubMed
234373623Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape.Nat Rev Immunol2021https://conductscience.org/library/papers/34373623PubMed
335221061Evaluating the in vitro efficacy of bovine lactoferrin products against SARS-CoV-2 variants of concern.J Dairy Sci2022https://conductscience.org/library/papers/35221061PubMed
434120909Open-Label Evaluation of Eteplirsen in Patients with Duchenne Muscular Dystrophy Amenable to Exon 51 Skipping: PROMOVI Trial.J Neuromuscul Dis2021https://conductscience.org/library/papers/34120909PubMed
534535792The biological and clinical significance of emerging SARS-CoV-2 variants.Nat Rev Genet2021https://conductscience.org/library/papers/34535792PubMed
632225175Structural basis of receptor recognition by SARS-CoV-2.Nature2020https://conductscience.org/library/papers/32225175PubMed
734471255Cellular host factors for SARS-CoV-2 infection.Nat Microbiol2021https://conductscience.org/library/papers/34471255PubMed
816700890Antisense oligonucleotides: from design to therapeutic application.Clin Exp Pharmacol Physiol2006https://conductscience.org/library/papers/16700890PubMed
934611326Mechanisms of SARS-CoV-2 entry into cells.Nat Rev Mol Cell Biol2022https://conductscience.org/library/papers/34611326PubMed
1032445440Remdesivir for the Treatment of Covid-19 - Final Report.N Engl J Med2020https://conductscience.org/library/papers/32445440PubMed
1133353982Gene regulation by long non-coding RNAs and its biological functions.Nat Rev Mol Cell Biol2021https://conductscience.org/library/papers/33353982PubMed
1229443664Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy.N Engl J Med2018https://conductscience.org/library/papers/29443664PubMed
1325614280Mipomersen, an antisense oligonucleotide to apolipoprotein B-100, reduces lipoprotein(a) in various populations with hypercholesterolemia: results of 4 phase III trials.Arterioscler Thromb Vasc Biol2015https://conductscience.org/library/papers/25614280PubMed
1433882225Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19.N Engl J Med2021https://conductscience.org/library/papers/33882225PubMed
1534381216Mechanism of molnupiravir-induced SARS-CoV-2 mutagenesis.Nat Struct Mol Biol2021https://conductscience.org/library/papers/34381216PubMed
1622614180Structure and nuclease resistance of 2',4'-constrained 2'-O-methoxyethyl (cMOE) and 2'-O-ethyl (cEt) modified DNAs.Chem Commun (Camb)2012https://conductscience.org/library/papers/22614180PubMed
1718258313Oligonucleotide antiviral therapeutics: antisense and RNA interference for highly pathogenic RNA viruses.Antiviral Res2008https://conductscience.org/library/papers/18258313PubMed
1834614326Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months.N Engl J Med2021https://conductscience.org/library/papers/34614326PubMed
1933600796Antisense technology: A review.J Biol Chem2021https://conductscience.org/library/papers/33600796PubMed
2034278671Efficient Inhibition of SARS-CoV-2 Using Chimeric Antisense Oligonucleotides through RNase L Activation*.Angew Chem Int Ed Engl2021https://conductscience.org/library/papers/34278671PubMed

See all 41 referencesDownload CSV of references

Cited by12

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.

PMIDTitleJournalYearIn PapersSource
42890159Structural insights into an aptainhibitor of the SARS-CoV-2 E protein using molecular docking, molecular dynamics, and biophysical analyses.Mol Ther Nucleic Acids2026https://conductscience.org/library/papers/42890159PubMed
41580734The silent epidemic within the pandemic: pathophysiology and prediction of post-COVID-19 diabetes.J Transl Med2026https://conductscience.org/library/papers/41580734PubMed
41226561Application of Antisense Oligonucleotides as an Alternative Approach for Gene Expression Control and Functional Studies.Int J Mol Sci2025https://conductscience.org/library/papers/41226561PubMed
40723836Endogenous Ribonucleases: Therapeutic Targeting of the Transcriptome Through Oligonucleotide-Triggered RNA Inactivation.Biomolecules2025https://conductscience.org/library/papers/40723836PubMed
40686860Antisense oligonucleotides targeting the SARS-CoV-2 nucleocapsid gene decrease viral titers in hamsters.Mol Ther Nucleic Acids2025https://conductscience.org/library/papers/40686860PubMed
39947217Targeting the SARS-CoV-2 reservoir in long COVID.Lancet Infect Dis2025https://conductscience.org/library/papers/39947217PubMed
39630134Decoding the genome of SARS-CoV-2: a pathway to drug development through translation inhibition.RNA Biol2024https://conductscience.org/library/papers/39630134PubMed
39599817Viral RNA Interactome: The Ultimate Researcher's Guide to RNA-Protein Interactions.Viruses2024https://conductscience.org/library/papers/39599817PubMed
38914784Mechanisms of Action of the US Food and Drug Administration-Approved Antisense Oligonucleotide Drugs.BioDrugs2024https://conductscience.org/library/papers/38914784PubMed
37626929Antisense Therapy for Infectious Diseases.Cells2023https://conductscience.org/library/papers/37626929PubMed
37459541Proxalutamide reduces SARS-CoV-2 infection and associated inflammatory response.Proc Natl Acad Sci U S A2023https://conductscience.org/library/papers/37459541PubMed
37318607Structure-Based Drug Design of RdRp Inhibitors against SARS-CoV-2.Top Curr Chem (Cham)2023https://conductscience.org/library/papers/37318607PubMed

Download CSV of cited by

Genes9

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36735698

GET https://conductscience.org/api/papers/v1/36735698/references?page=2